SUPERNUS PHARMACEUTICALS, INC. (SUPN) Net income 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$38.6MFY2025 · since FY2016: $91.2M → -$38.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.6M | -152.2% |
| FY2024 | $73.9M | +5584.6% |
| FY2023 | $1.3M | -97.9% |
| FY2022 | $60.7M | +13.7% |
| FY2021 | $53.4M | -57.9% |
| FY2020 | $127.0M | +12.3% |
| FY2019 | $113.1M | +1.9% |
| FY2018 | $111.0M | +93.8% |
| FY2017 | $57.3M | -37.2% |
| FY2016 | $91.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice